Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile
Journal for ImmunoTherapy of Cancer

@jitcancer

The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD

ID: 1150769339466952705

linkhttps://jitc.bmj.com/ calendar_today15-07-2019 14:09:25

5,5K Tweet

8,8K Followers

1,1K Following

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo
Journal for ImmunoTherapy of Cancer
@jitcancer

7 months ago

Next, they pinpointed specific WHO-classified antineoplastic and immunomodulating agents that significantly heighten the risk of breakthrough COVID-19 infections. This critical insight is key for enhancing patient care alongside vaccines. 4/9

Next, they pinpointed specific WHO-classified antineoplastic and immunomodulating agents that significantly heighten the risk of breakthrough COVID-19 infections. This critical insight is key for enhancing patient care alongside vaccines. 4/9